Evidence map›Paper›PMID 33662042›Full record

ArticlePloS one2021

The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine.

Ruwaa I Mohamed, Salma A Bargal, Asmaa S Mekawy, Iman El-Shiekh, Nurcan Tuncbag, Alaa S Ahmed, Eman Badr, Menattallah Elserafy

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ruwaa I MohamedCenter for Informatics Sciences (CIS), Nile University, Giza, Egypt.
Salma A BargalCenter for Genomics, Helmy Institute for Medical Sciences, Zewail City of Science and Technology, Giza, Egypt.ORCID 0000-0001-9675-7523
Asmaa S MekawyCenter for Genomics, Helmy Institute for Medical Sciences, Zewail City of Science and Technology, Giza, Egypt.ORCID 0000-0002-7238-386X
Iman El-ShiekhCenter for Genomics, Helmy Institute for Medical Sciences, Zewail City of Science and Technology, Giza, Egypt.
Nurcan TuncbagGraduate School of Informatics, Department of Health Informatics, Middle East Technical University, Ankara, Turkey.ORCID 0000-0002-0389-9459
Alaa S AhmedCenter for Genomics, Helmy Institute for Medical Sciences, Zewail City of Science and Technology, Giza, Egypt.
Eman BadrUniversity of Science and Technology, Zewail City of Science and Technology, Giza, Egypt.ORCID 0000-0001-9531-2266
Menattallah ElserafyCenter for Genomics, Helmy Institute for Medical Sciences, Zewail City of Science and Technology, Giza, Egypt.ORCID 0000-0002-0272-8498

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the era of precision medicine, analyzing the transcriptomic profile of patients is essential to tailor the appropriate therapy. In this study, we explored transcriptional differences between two invasive breast cancer subtypes; infiltrating ductal carcinoma (IDC) and lobular carcinoma (LC) using RNA-Seq data deposited in the TCGA-BRCA project. We revealed 3854 differentially expressed genes between normal ductal tissues and IDC. In addition, IDC to LC comparison resulted in 663 differentially expressed genes. We then focused on DNA repair genes because of their known effects on patients' response to therapy and resistance. We here report that 36 DNA repair genes are overexpressed in a significant number of both IDC and LC patients' samples. Despite the upregulation in a significant number of samples, we observed a noticeable variation in the expression levels of the repair genes across patients of the same cancer subtype. The same trend is valid for the expression of miRNAs, where remarkable variations between patients' samples of the same cancer subtype are also observed. These individual variations could lie behind the differential response of patients to treatment. The future of cancer diagnostics and therapy will inevitably depend on high-throughput genomic and transcriptomic data analysis. However, we propose that performing analysis on individual patients rather than a big set of patients' samples will be necessary to ensure that the best treatment is determined, and therapy resistance is reduced.

Indexed as

DNA RepairGene Expression Regulation, NeoplasticBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, LobularFemaleHumansMicroRNAsPrecision MedicineTranscriptomeUp-RegulationMicroRNAs

Identifiers

PMID33662042
PMCPMC7932549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.